The Patent Finder

Aim Therapeutics Inc.

Also on record
Records under this name other than patents Aim Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Aim Therapeutics Inc.

PatentTitleStatus Expires Confidence
US 7,153,835Anti-inflammatory peptides
Lapsed on the fee record
Ended Dec 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 26, 2018From the USPTO record
US 7,833,986Anti-inflammatory peptides
Lapsed on the fee record
Ended Nov 16, 2018 · From the USPTO record
Lapsed on the fee recordEnded Nov 16, 2018From the USPTO record
US 6,852,697Peptides for treatment of inflammation and shock
Lapsed on the fee record
Ended Feb 8, 2017 · From the USPTO record
Lapsed on the fee recordEnded Feb 8, 2017From the USPTO record
US 7,094,760Peptides for treatment of inflammation and shock
Lapsed on the fee record
Ended Aug 22, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2014From the USPTO record
US 6,586,403Treating allergic reactions and inflammatory responses with tri-and dipeptides
Lapsed on the fee record
Ended Jul 1, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jul 1, 2011From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited